Biomarker-guided targeted and immunotherapies in malignant pleural mesothelioma

Malignant pleural mesothelioma (MPM) is a lethal thoracic malignancy whose incidence is still increasing worldwide. MPM is characterized by frequent inactivation of tumor-suppressor genes (TSGs), e.g., the homozygous deletion of CDKN2A/2B and various genetic alterations that inactivate BAP1, NF2, LA...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Haitang, Xu, Duo, Schmid, Ralph A., Peng, Ren-Wang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7672749/
https://www.ncbi.nlm.nih.gov/pubmed/33240401
http://dx.doi.org/10.1177/1758835920971421

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7672749/
https://www.ncbi.nlm.nih.gov/pubmed/33240401
http://dx.doi.org/10.1177/1758835920971421

Ejemplares similares